Stocktobuy
Header and shoulder pattern 1) head and shoulder pattern in chart
2) three years time taken buy chart to complete pattern
3) we analyse weekly charts
4) for safer side 395 closing must to get stock momentum to reach Target
5) Target 470 first and second 530 level
6) to reach this Target must close 395 level
7) closely watch volume in chart how building helps to build header and shoulder pattern
8) no recommendation for the buy and sell
TRADE SETUP_WAVE V IN ABBOT_15-20% MOVEAbbott India Ltd. is seen coming out of a fourth wave triangle and is expected to have completed wave i of V.
The stock had remained in a 3month long correction during the fourth wave between Aug and Nov.
The stock is currently close to the support area of 23000 and is expected to settle and reverse from around here.
The final projected target for fifth wave completion comes in at around 27.5K-29K zone.
Note*-The views expressed are personal observations/opinions. Kindly do your own analysis before taking up any trading positions.
TRADE SETUP_TATA POWER_DIWALI SPECIALHappy Diwali to everyone. I wish for prosperity and happiness to all seeing this post.
Tata power is seen in an Elliot wave structure on hourly chart. The stock will now look to reach the 260 mark in wave v to complete what it started on Oct. 26th.
There is also a reverse head and shoulder pattern developing on the hour chart. The neckline of the pattern is yet to be broken, but chances are high the stock might do it and quickly march upwards to 260 then on.
Please note the company had reported a net profit rise of 8%(Y-O-Y) on 8th of Nov. when it announced the results.
Note*-Trading is risky and can lead to financial loses. Kindly study the charts and fundamentals of company before taking any financial positions.
IDFC Ltd - Value pick available at very attractive valuationIDFC Ltd - CMP-117.05, Target-200, SL-75
Infrastructure Financing, Market Cap 18,735+ Cr
Available at very attractive valuation
PE 4.52, PB 1.55, Dividend Yield 10.25
FIIs holdings 20.03%, DII 32.10%
TRADE SETUP_LIC HOUSINGFIN_10% upsideThe stock was seen rising in march 2023 in wave 1 all the way till June 2023. The retracement to this wave came in next 1month through the month of July.
Then from July till late September the stock was seen advancing up in wave 3.It spend the month of October subsequently in wave 4 corrective phase and now towards the year end, the stock is ready for wave 5 take off and can move towards 500 mark in November-December.
It should be noted that since the wave 3 was shorter than wave 1 it should be presumed that wave 5 will be the shortest and therefore a modest target of 500 is projected for this stock.
The stock is currently near a strong support area of 450.
440 can be used as a SL.
Please note the wave counts have been studied and marked on a 3hour chart.
Note*- Views expressed here are my personal observations/opinions. Always do your own analysis/research before taking up any financial position.
NSE:Lupin -trend change on card???
NSE:LUPIN
Lupin Limited is an India-based pharmaceutical company. The Company develops and commercializes a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) in over 100 markets in the United States, India, South Africa, and across the Asia Pacific, Latin America, and others. It offers vitamins, minerals, supplements and neurological products. It has presence in the cardiovascular, dialectology, asthma, paediatrics, central nervous system, gastro-intestinal, anti-infectives and nonsteroidal anti-inflammatory drug therapy segments. Its complex generics portfolio includes Filgrastim, Peg-Filgrastim, Etanercept and Albuterol, and others. Its biosimilar products include Filgrastim, Peg-Filgrastim and Etanercept. Its specialty products consist of Solosec and NaMuscla. Its over-the-counter products include Softovac, Lupizyme, Aptivate, Lupisafe, Be One, V-Bath, and others. It supplies APIs for anti-retroviral, anti-malarial and others.
Disc: Invested, please do you own research